{"id":"NCT00440466","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients","officialTitle":"A Randomized, Open-label, Multicenter Study of Epoetin Alfa Comparing Two Extended Dosing Regimens, Once-every-two-weeks and Once-every-four-weeks, With the Once-weekly Dosing Regimen for Maintenance Treatment in Anemic Subjects With Chronic Kidney Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2009-03","completion":"2009-03","firstPosted":"2007-02-27","resultsPosted":"2011-04-14","lastUpdate":"2014-04-21"},"enrollment":430,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia","Renal Diseases"],"interventions":[{"type":"DRUG","name":"epoetin alfa","otherNames":[]},{"type":"DRUG","name":"epoetin alfa","otherNames":[]},{"type":"DRUG","name":"epoetin alfa","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"003","type":"EXPERIMENTAL"},{"label":"002","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with anemia associated with chronic kidney disease, is not less effective than treatment with epoetin alfa that is given once a week","primaryOutcome":{"measure":"Change in Hemoglobin Concentration in Grams Per Deciliter (g/dL) From Baseline to the Average of the Last 12 Weeks of Treatment","timeFrame":"from baseline (Week 1) to the last 12 weeks of treatment","effectByArm":[{"arm":"Epoetin Alfa QW","deltaMin":-0.02,"sd":0.728},{"arm":"Epoetin Alfa Q2W","deltaMin":-0.1,"sd":0.774},{"arm":"Epoetin Alfa Q4W","deltaMin":-0.19,"sd":0.738}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":66,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=58&filename=CR010414_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":108},"commonTop":["Hypertension","Oedema","Urinary tract infection","Hyperkalaemia","Oedema peripheral"]}}